A Phase IIa Trial of the New Tuberculosis Vaccine, MVA85A, in HIV- and/or Mycobacterium tuberculosis–infected Adults

Rationale: Novel tuberculosis (TB) vaccines should be safe and effective in populations infected with Mycobacterium tuberculosis (M.tb) and/or HIV for effective TB control. Objective: To determine the safety and immunogenicity of MVA85A, a novel TB vaccine, among M.tb- and/or HIV-infected persons in...

Full beskrivning

Sparad:
Bibliografiska uppgifter
Huvudupphovsmän: Scriba, Thomas J., Tameris, Michele, Smit, Erica, van der Merwe, Linda, Hughes, E. Jane, Kadira, Blessing, Mauff, Katya, Moyo, Sizulu, Brittain, Nathaniel, Lawrie, Alison, Mulenga, Humphrey, de Kock, Marwou, Makhethe, Lebohang, Janse van Rensburg, Esme, Gelderbloem, Sebastian, Veldsman, Ashley, Hatherill, Mark, Geldenhuys, Hendrik, Hill, Adrian V. S., Hawkridge, Anthony, Hussey, Gregory D., Hanekom, Willem A., McShane, Helen, Mahomed, Hassan
Materialtyp: Artigo
Språk:Inglês
Publicerad: American Thoracic Society 2012
Ämnen:
Articles
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC3326425/
https://ncbi.nlm.nih.gov/pubmed/22281831
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1164/rccm.201108-1548OC
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk